Ocean Biomedical, Inc. (OTCPK: OCEA)
Health Care · Biotechnology · US
$0.00
+60.00% today · -38.5% 1Y
Ocean Biomedical, Inc. (OTCPK: OCEA) operates in the Biotechnology industry within the Health Care sector. The company is valued at $185.89K and employs 7 people.
Over the last twelve months the share price has lost 38.5%, trading between 0.00 and 0.01.
Tweenvest scores Ocean Biomedical, Inc. across four factors: quality 20/100, value 54/100. Its strongest factor is value.
OCEA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $185.89K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.71
- Dividend yield
- —
- Beta (5Y)
- 0.38
- 52-week high
- $0.01
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 232.37M
- Employees
- 7
- Next earnings
- —
About Ocean Biomedical, Inc.
Ocean Biomedical, Inc. operates as a biopharmaceutical firm committed to identifying and advancing novel therapeutic solutions for various medical challenges, including cancer, fibrotic disorders, infectious illnesses, and inflammation. The company's pipeline includes the development of both mono-specific and bi-specific humanized monoclonal antibodies (mAbs). These candidates are specifically designed to target Chi3l1, offering potential treatments for non-small cell lung cancer and glioblastoma multiforme. Additionally, they are progressing a small molecule drug candidate aimed at Chit1, intended to address Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. Leveraging its proprietary WPDS platform, Ocean Biomedical is also developing three further product candidates. These encompass a promising malaria vaccine, a humanized mAb therapeutic for malaria that targets the Plasmodium falciparum glutamic-acid-rich protein (PfGARP), and a small molecule malaria therapeutic also designed to interact with PfGARP. Furthermore, a treatment candidate for hospitalized COVID-19 patients is also under development. The company, established in 2019, maintains its operations in Providence, Rhode Island.
- ISIN
- US67644C1045
- Founded
- 2019
- Listed since
- Nov 8, 2021
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Nextel Medical Corp.OTCPK: MAJI | $239.24K | $0.00 | -2.93% |
| WPD Pharmaceuticals Inc.CNSX: WBIO | $233.63K | CA$— | — |
| Beroni Group LimitedOTCPK: BNIG.F | $216.88K | $— | — |
| NAVCO Pharmaceuticals Inc.TSXV: NAV | $200.86K | CA$0.01 | — |
| Endonovo Therapeutics, Inc.OTCPK: ENDV | $180.76K | $0.00 | +100.00% |
| Regen BioPharma, Inc.OTCPK: RGBP | $167.53K | $0.00 | -50.00% |
| Biosergen AB (publ)OM: BIOSGN | $142.46K | Skr0.50 | +3.77% |
| Oxurion NVENXTBR: OXUR | $126.66K | €0.00 | -33.33% |
Figures last refreshed Oct 18, 2026.